Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Incy crawled time : 16:00 save search
Anju Software Unveils Strategies for Data-Driven Decision-Making in Clinical Research at SCOPE Orlando 2024
Published: 2024-02-08 (Crawled : 16:00) - prnewswire.com
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.02%
H: 0.65%
C: 0.02%
software research
Incyte Highlights Growth Opportunities and Provides Business Updates at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 16:00) - biospace.com/
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.55%
H: 1.45%
C: 1.42%
conference business growth
Incyte Abandons Phase III Trial for Myelofibrosis Treatment
Published: 2023-03-06 (Crawled : 16:00) - biospace.com/
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -2.27%
H: 0.58%
C: 0.07%
treatment trial
Hidradenitis Suppurativa Market is Expected to Grow at a Significant CAGR of 10.2% by 2032 | DelveInsight
Published: 2023-01-11 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.45%
H: 2.09%
C: 1.71%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.04%
H: 0.63%
C: 0.2%
expected market
Rheumatoid Arthritis Market is Expected to Showcase Significant Growth in the 7MM at a Minimal CAGR of 1.9% During the Study Period (2019-2032), Predicts DelveInsight
Published: 2023-01-09 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.29%
H: 0.27%
C: -3.89%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.02%
H: 0.36%
C: -2.56%
expected growth study market
Propulsion of Pancreatic Cancer Pipeline as Novel and Extensive 170+ Therapies Likely to Enter in the Treatment Domain | DelveInsight
Published: 2023-01-02 (Crawled : 16:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
| Email alert
Add to watchlist
RCUS 4 | $14.59 -1.69% 0.0% 600K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
QLGN | $0.301 -3.43% -3.55% 30K
|
Health Technology
| Email alert
Add to watchlist
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
| Email alert
Add to watchlist
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
| Email alert
Add to watchlist
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
| Email alert
Add to watchlist
GRTX | $0.1833 -1.45% -1.47% 800K
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
treatment cancer pancreatic
Myelofibrosis Market is Expected to Grow at a CAGR of 7.3% by 2032 | DelveInsight
Published: 2022-12-19 (Crawled : 16:00) - prnewswire.com
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.5%
H: 0.93%
C: -1.26%
GERN | $3.69 -1.07% -1.08% 8.2M
|
Health Technology
|
| O: -0.88%
H: 0.88%
C: -9.73%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: 0.0%
H: 0.35%
C: -5.09%
expected market
Esophageal Squamous Cell Carcinoma Pipeline Looks Promising as 45+ Companies Working in the Domain, Assesses DelveInsight
Published: 2022-10-25 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.03%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.4%
H: 1.68%
C: 1.38%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
LPTX | $2.81 -5.07% -5.34% 200K
|
Health Technology
|
| O: -3.0%
H: 7.63%
C: 2.55%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.03%
H: 0.72%
C: -0.1%
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: -0.7%
H: 5.5%
C: 3.97%
BCEL P | $0.0761 0.0% 350K
|
Health Technology
|
| O: 2.76%
H: 1.34%
C: 0.0%
companies cell carcinoma
Esophageal Cancer Clinical Trial Pipeline Insights Featuring 80+ Companies | DelveInsight
Published: 2022-10-11 (Crawled : 16:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.2%
H: 2.82%
C: 2.38%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
LPTX | $2.81 -5.07% -5.34% 200K
|
Health Technology
|
| O: -1.15%
H: 5.35%
C: -0.7%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.27%
H: 0.59%
C: -0.75%
CRIS | $14.59 -4.14% -4.32% 10K
|
Health Technology
|
| O: -2.18%
H: 3.89%
C: -1.35%
BCEL P | $0.0761 0.0% 350K
|
Health Technology
|
| O: -1.26%
H: 5.1%
C: -1.91%
ATNX | $0.2031 -7.78% 1.9M
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: -11.04%
companies trial cancer
Hand Eczema Market to Boost at a CAGR of 7.3% by 2032 | DelveInsight
Published: 2022-08-29 (Crawled : 16:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.7%
H: 0.49%
C: -1.02%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.08%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.9%
H: 0.45%
C: -0.47%
eczema market
Bladder Cancer Clinical Trial Pipeline Insights Featuring 100+ Companies | DelveInsight
Published: 2022-08-23 (Crawled : 16:00) - prnewswire.com
IBRX | $5.265 7.23% 6.74% 4.6M
|
Manufacturing
|
| O: 0.27%
H: 6.27%
C: 4.0%
URGN | $13.78 -3.37% -3.48% 390K
|
Health Technology
|
| O: 0.64%
H: 0.32%
C: -0.63%
TARA | $2.62 -4.73% -4.96% 210K
|
Health Technology
|
| O: -0.38%
H: 3.83%
C: 1.73%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.49%
H: 0.36%
C: -0.33%
companies trial bladder cancer
Glioma Pipeline Insights | Clinical Trial Research Evaluation Report By DelveInsight
Published: 2022-08-08 (Crawled : 16:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.22%
H: 1.82%
C: 0.62%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.0%
H: 2.7%
C: 2.55%
research report trial
Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China
Published: 2022-08-04 (Crawled : 16:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.16%
H: 0.02%
C: -1.42%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.09%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.12%
H: 0.73%
C: -0.99%
collaboration china sanofi
AnHeart Therapeutics and Innovent Biologics Present Updated Phase 2 Efficacy and Safety Data of Taletrectinib (ROS1 Inhibitor) at ASCO 2022
Published: 2022-06-06 (Crawled : 16:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 3.83%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
therapeutics asco phase 2
LAG 3 Next Generation Immunotherapy Market to Progress Upto A Whopping 6 Billion USD with a CAGR of 26.3% in the 7MM for the Forecast Period of 2025-2035, Estimates DelveInsight
Published: 2022-05-30 (Crawled : 16:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
| Email alert
Add to watchlist
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
| Email alert
Add to watchlist
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
immunotherapy market
The Chronic Gout Market is Expected to Witness Remarkable Growth at a CAGR of 5.44% During the Study Period (2018-30), Assesses DelveInsight
Published: 2022-05-25 (Crawled : 16:00) - prnewswire.com
SELB 4 | $0.8812 -8.0% 2.12% 0
|
Health Technology
|
| O: -1.53%
H: 5.62%
C: 3.87%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 1.09%
H: 0.0%
C: 0.0%
expected growth market
The Ankylosing Spondylitis Market to Surge at a Significant CAGR of 5.4% by 2032, Estimates DelveInsight
Published: 2022-05-09 (Crawled : 16:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.93%
H: 0.48%
C: -1.46%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -1.44%
H: 0.82%
C: -1.98%
market
The Severe Hypertriglyceridemia Market is Expected to Increase with a CAGR of 8.1% During the Study Period (2019-32) | DelveInsight
Published: 2022-05-05 (Crawled : 16:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 3.73%
H: 0.09%
C: -3.98%
ARWR | $22.33 -1.24% -1.25% 960K
|
Health Technology
|
| O: -0.98%
H: 0.23%
C: -5.52%
ETNB | $9.08 2.25% 2.2% 1M
|
Health Technology
|
| O: -0.44%
H: 8.85%
C: 6.64%
expected market
The Chronic Pulmonary Hypertension Market is Expected to Witness Growth at a CAGR of 28.14% During the Study Period (2019-32) | DelveInsight
Published: 2022-05-04 (Crawled : 16:00) - prnewswire.com
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
hypertension expected growth market
Incyte Announces Positive CHMP Opinion for Capmatinib (Tabrecta®) for the Treatment of METex14 Advanced Non-Small Cell Lung Cancer
Published: 2022-04-22 (Crawled : 16:00) - biospace.com/
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.4%
H: 1.01%
C: 0.04%
tabrecta treatment chmp positive cancer
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.